Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NH0U
|
||||
| Former ID |
DIB003113
|
||||
| Drug Name |
HYG-440
|
||||
| Synonyms |
HYG-410; HYG-420; HYG-430; Androgen receptor antagonists (topical, dermatological disorder), hygeia
|
||||
| Indication | Dermatological disease [ICD10:L00-L99] | Investigative | [552008] | ||
| Company |
Yale University
|
||||
| Target and Pathway | |||||
| Target(s) | Androgen receptor | Target Info | Antagonist | [552008] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Coregulation of Androgen receptor activity | |||||
| Regulation of Androgen receptor activity | |||||
| Nongenotropic Androgen signaling | |||||
| Regulation of nuclear beta catenin signaling and target gene transcription | |||||
| FOXA1 transcription factor network | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.